@misc{indiciae19d96c853acd,
  title = {Evolving Role of Immunotherapy in Advanced Esophageal Squamous Cell Carcinoma: Are Programmed Death-Ligand 1 (PD-L1) Cutoffs Still Relevant?},
  author = {Praloy Basu},
  year = {2026},
  doi = {10.7759/cureus.114584},
  url = {https://pubmed.ncbi.nlm.nih.gov/42746208/},
  note = {Source identifier: 42746208}
}